BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 499314)

  • 1. Long-term hemodynamic effects of penbutolol at rest and during exercise in essential hypertension.
    Lund-Johansen P
    Eur J Clin Pharmacol; 1979 Sep; 16(3):149-53. PubMed ID: 499314
    [No Abstract]   [Full Text] [Related]  

  • 2. Penbutolol: comparison of its antihypertensive effect with that of alpha-methyldopa in patients with primary hypertension.
    Vierhapper H; Dudczak R; Waldhäusl W
    Arzneimittelforschung; 1980; 30(6):1008-11. PubMed ID: 7191259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the beta blocker penbutolol on human hemodynamic parameters and the heart conduction system].
    Biamino G; Schüren KP; von Leitner E
    Verh Dtsch Ges Inn Med; 1978; (84):697-700. PubMed ID: 742102
    [No Abstract]   [Full Text] [Related]  

  • 4. Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism.
    Frishman WH; Covey S
    J Clin Pharmacol; 1990 May; 30(5):412-21. PubMed ID: 2189902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term hemodynamic effects of bunitrolol at rest and during exercise in essential hypertension.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1979; 1(1):77-83. PubMed ID: 94384
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of penbutolol on the hemodynamics in patients with hypertensive disease].
    Demin AA; Mitrokhin VE
    Farmakol Toksikol; 1986; 49(5):74-6. PubMed ID: 3770181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penbutolol: a preliminary review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1981 Jul; 22(1):1-25. PubMed ID: 7261952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penbutolol: a new beta-adrenergic blocking agent.
    Schlanz KD; Thomas RL
    DICP; 1990 Apr; 24(4):403-8. PubMed ID: 2183495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutolol.
    Lameijer LD; Voermans LA; Houtzagers JJ; Chadha DR
    Eur J Clin Pharmacol; 1981; 21(2):93-6. PubMed ID: 7042370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The excretion of renal enzymes during rest and exercise: a double-blind comparison between placebo and penbutolol.
    Verho M; Färber G; Heinen B; Grötsch H
    Int J Clin Pharmacol Res; 1987; 7(1):27-32. PubMed ID: 2884191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic long-term effects of atenolol at rest and during exercise in essential hypertension.
    Lund-Johansen P
    Postgrad Med J; 1977; 53 Suppl 3():99-101. PubMed ID: 928275
    [No Abstract]   [Full Text] [Related]  

  • 12. Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.
    Hansson BG; Hökfelt B
    Eur J Clin Pharmacol; 1975 Oct; 9(1):9-19. PubMed ID: 9298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic dose-response effects of i.v. penbutolol in angina pectoris.
    Silke B; Verma SP; Hussain M; Nelson GI; Okoli RC; Taylor SH
    Br J Clin Pharmacol; 1983 Nov; 16(5):529-35. PubMed ID: 6315039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension.
    Lund-Johansen P; Ohm OJ
    Br J Clin Pharmacol; 1977 Apr; 4(2):147-51. PubMed ID: 861129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of penbutolol and propranolol on glomerular filtration rate in hypertensive patients with impaired renal function.
    van der Meulen J; Reijn E; Heidendal GA; Oe PL; Donker AJ
    Br J Clin Pharmacol; 1986 Oct; 22(4):469-74. PubMed ID: 3533129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the effects of penbutolol and propranolol in the treatment of angina pectoris.
    Hillis WS; Tweddel AC; Murray RG; Lawrie TD
    Arzneimittelforschung; 1980; 30(9):1595-9. PubMed ID: 7006619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic changes at rest and during exercise in long-term clonidine therapy of essential hypertension.
    Lund-Johansen P
    Acta Med Scand; 1974; 195(1-2):111-5. PubMed ID: 4817078
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.
    Lund-Johansen P
    Br J Clin Pharmacol; 1976 Jun; 3(3):445-51. PubMed ID: 973971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carteolol and penbutolol for hypertension.
    Med Lett Drugs Ther; 1989 Jul; 31(797):70-1. PubMed ID: 2568577
    [No Abstract]   [Full Text] [Related]  

  • 20. Single and divided doses of penbutolol.
    Müller FO; Hundt HK; Bromley PA; Torres J; Vanderbeke O
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):528-35. PubMed ID: 436357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.